Heather R. Greene, MSN, FNP, AOCNP®, and Lee S. Schwartzberg, MD, FACP, discussed the current and future treatment landscape for triple-negative breast cancer, including recent and emerging data on approved treatments, novel therapeutic options being investigated, and best practices for identifying and monitoring adverse events associated with PARP and immune checkpoint inhibitors at JADPRO Live 2019.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857324 | PMC |
| http://dx.doi.org/10.6004/jadpro.2020.11.3.10 | DOI Listing |
Publication Analysis
Top Keywords
triple-negative breast
8
breast cancer
8
expert insights
4
insights triple-negative
4
cancer preparing
4
preparing wave
4
wave treatments
4
treatments heather
4
heather greene
4
greene msn
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!